Detailed price information for Royalty Pharma Plc Cl A (RPRX-Q) from The Globe and Mail including charting and trades.

Gilead Sciences wins 2025 Prix Galien USA Award for Best Pharmaceutical Product for Yeztugo: Foster City, California Monday, November 3, 2025, 17:00 Hrs [IST] Gilead Sciences, Inc ...

Cipla acquires Inzpera Healthsciences in a deal heralding pharma's new era of empathetic innovation: Our Bureau, Chennai Wednesday, November 5, 2025, 13:50 Hrs [IST] Pharmaceutica ...

Greenhaven Associates has taken a new swing in Avantor, buying roughly $228 million worth of Avantor (AVTR) stock after a ...

Powered by the data and AI capabilities of SAS Viya, the life sciences solution streamlines drug development to deliver new therapies to patients faster CARY, N.C., /PRNewswire/ -- In today's rapidly ...

Market opportunities arise from the growing need for modernization and compliance assurance in FDA-regulated industries focusing on data integrity. Emphasizing cloud computing, automation, and mobile ...

West Pharmaceutical Services, Inc. ( WST) Jefferies London Healthcare Conference 2025 November 18, 2025 5:00 AM EST ...

Dr. Adrian Bot joins Immuthera to support the company with his unique experience in commercialization of groundbreaking cell therapies Dr. Adrian ...

Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatmentExpects to initiate CDI-988 Phase 1b ...

Jefferies London Healthcare Conference 2025 November 18, 2025 9:30 AM ESTCompany ParticipantsUdit Batra - President, CEO ...

Strong IP keeps collaboration alive, allowing companies to attract capital, strike partnerships, and bring innovations to patients, according to legal experts at Ice Miller.

The third quarter of 2025 closed amid growing macroeconomic strain, policy unpredictability and renewed investor focus on execution risk. While ...